Pancreatic Cancer (Zoom)

lunch n learn with the doctors

INSTRUCTIONS TO CONNECT

  • To join our Zoom Meeting click on (or copy/paste) link: https://us02web.zoom.us/j/83508528828
  • Meeting ID: 835 0852 8828
  • Password: 918009
  • To dial-in via telephone for audio instead of joining the webinar: 929-436-2866

Registration requested for this free event. Please register at:

https://us02web.zoom.us/meeting/register/tZcod-GtrDMiGNxBOIbf1z4_M8XObqMG96vx

In this multidisciplinary talk conducted virtually, Drs. Pepek & Salwitz, along with Drs. Broder and Kennedy, will conduct a comprehensive review of the diagnosis, treatment, and management of Pancreatic Cancer. Topics include:

  • The challenge of early diagnosis and screening - Who is at risk?
  • Advances in diagnosis, staging and testing
  • Controlling the symptoms
  • Steps in therapy and the importance of teamwork:
    • The role of the gastroenterologist
    • The role of the surgeon
    • The role of the radiation oncologist
    • The role of the oncologist
  • Breakthroughs and Research
  • How we get to a cure

Please note, the doctors presenting will not be able to offer personal medical advice to attendees during this program.

About the Speakers

Dr. Timothy Kennedy completed his medical school training at Georgetown University School of Medicine, followed by a general surgery residency at Northwestern University. Following completion of surgical oncology and minimally invasive surgery fellowships, he spent the past six years at Montefiore Medical Center/Albert Einstein College of Medicine as an Assistant Professor of Surgery in the section of upper gastrointestinal and pancreas surgery. He utilizes minimally invasive techniques in management of many patients with esophageal, gastric, and pancreatic malignancies. He serves as principal investigator on a Phase II clinical trial utilizing CRS and HIPEC for patients with peritoneal surface malignancy from peritoneal mesothelioma, pseudomyxoma peritonei, appendiceal cancer, colon cancer and gastric cancer. As a member of the Gastrointestinal/Hepatobiliary Program at Rutgers Cancer Institute of New Jersey, Dr Kennedy works collaboratively with other members of a multidisciplinary team including medical oncologists, radiation oncologists, gastroenterologists, radiologists, pathologists, genetic counselors, nutritionists, social workers, and nurses to help educate patients about their disease and help them navigate their treatment options.

Dr. Arkady Broder is the chief of the division of Gastroenterology and Hepatology at Saint Peter’s University Hospital. He holds a clinical faculty position at Rutgers Robert Wood Johnson Medical School and is the program director of the Medical School’s Gastroenterology Fellowship Program at Saint Peter's University Hospital. Dr. Broder is a recipient of the Excellence in GI Practice Operations Recognition Program from the American Society of Gastrointestinal Endoscopy.

James Salwitz, MD received his medical degree from University of Medicine and Dentistry of New Jersey, Rutgers Medical School. He completed his residency in Internal Medicine at the McGraw Medical Center of Northwestern University and his fellowship in Oncology at the Division of Cancer Treatment, National Cancer Institute, National Institutes of Health. He is board certified in Internal Medicine, Medical Oncology, and Hospice & Palliative Medicine. Dr. Salwitz is also a clinical professor at Rutgers Medical School and holds leadership ppositions at Robert Wood Johnson University Hospital; New Jersey Medical Society; Middlesex County Medical Society, and The Amy Feinman Behar Foundation for Cancer Prevention.

Dr. Joseph (Josh) Pepek received his Bachelor of Arts degree with honors from Georgetown University. As an undergraduate, he played for Georgetown’s varsity baseball team. Dr. Pepek obtained his medical degree from Georgetown University School of Medicine and afterwards served as a medical officer for the United States Navy. During his naval career, Dr. Pepek completed a surgery internship at Naval Medical Center in San Diego, CA. He then deployed to Iraq with the U.S. Navy Seabees during Operation Iraqi Freedom. He also was the medical officer for the Marine Corps Chemical Biological Incident Response Force in Indian Head, Maryland. Dr. Pepek then completed his radiation oncology residency at Duke University where he served as chief resident. He has presented his research at national meetings and has authored a number of peer reviewed journal articles.

Event Date
-